Pediatric Neurosurgery

Case Report

Successful Multimodal Therapies for a Primary Atypical Teratoid/Rhabdoid Tumor in the Cervical Spine

Yano S. · Hida K. · Kobayashi H. · Iwasaki Y.

Author affiliations

Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan

Related Articles for ""

Pediatr Neurosurg 2008;44:406–413

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Case Report

Received: May 21, 2007
Accepted: February 05, 2008
Published online: August 15, 2008
Issue release date: August 2008

Number of Print Pages: 8
Number of Figures: 4
Number of Tables: 2

ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)

For additional information: https://www.karger.com/PNE

Abstract

Atypical teratoid/rhabdoid tumor (AT/RT) occurring in the central nervous system is a high-grade malignant tumor, and its prognosis is poor for patients younger than 3 years of age. In this article, we present a case of infant AT/RT in the cervical spine and its successful treatment by intensive chemotherapy. The patient, a 1.75-year-old girl, developed an acute, progressive tetraparesis. MRI revealed a large, intradural mass in the cervical spine.Total surgical resection was performed, and the specimen was diagnosed as AT/RT. Continuously, she received intensive chemotherapy using thiotepa with autologous bone marrow transplantation. At the age of nearly 3 years, she received radiation therapy to the local tumor bed and craniospinal axis. She is now 4 years old and has been maintained in complete remission with a good clinical course and no neurological deficit. The success of this treatment for the patient was that we could prevent tumor recurrence until she was able to receive radiotherapy.

© 2008 S. Karger AG, Basel




Related Articles:


References

  1. Biegel JA, Kalpana G, Knudsen ES, Packer RJ, Roberts CW, Thiele CJ, Weissman B, Smith M: The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res 2002;62:323–328.
  2. Burger PC, Yu IT, Tihan T, Friedman HS, Strother DR, Kepner JL, Duffner PK, Kun LE, Perlman EJ: Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma. A Pediatric Oncology Group Study. Am J Surg Pathol 1998;22:1083–1092.
  3. Cheng YC, Lirng JF, Chang FC, Guo WY, Teng MM, Chang CY, Wong TT, Ho DM: Neuroradiological findings in atypical teratoid/rhabdoid tumor of the central nervous system. Acta Radiol 2005;46:89–96.
  4. Rorke LB, Packer RJ, Biegel JA: Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 1996;85:56–65.
  5. Paul K, Webster KC: World Health Organization Classification of Tumours – Pathology and Genetics of Tumours of the Nervous System. Lyon, IARC, 2000, pp 145–148.
  6. Lefkowitz IB, Rorke LB, Packer RJ, Sutton LN, Siegel KR, Katnick RJ: Atypical teratoid tumor of infancy: definition of an entity. Ann Neurol 1987;22:448–449.
    External Resources
  7. Bambakidis NC, Robinson S, Cohen M, Cohen AR: Atypical teratoid/rhabdoid tumors of the central nervous system: clinical, radiographic and pathologic features. Pediatr Neurosurg 2002;37:64–70.
  8. Bannykh S, Duncan C, Ogle E, Baehring JM: Atypical teratoid/rhabdoid tumor of the spinal canal. J Neurooncol 2006;76:129–130.
  9. Biegel JA, Rorke LB, Packer RJ, Emanuel BS: Monosomy 22 in rhabdoid or atypical tumors of the brain. J Neurosurg 1990;73:710–714.
  10. Chen ML, McComb JG, Krieger MD: Atypical teratoid/rhabdoid tumors of the central nervous system: management and outcomes. Neurosurg Focus 2005;18:1–5.
    External Resources
  11. Tamiya T, Nakashima H, Ono Y, Kawada S, Hamazaki S, Furuta T, Matsumoto K, Ohmoto T: Spinal atypical teratoid/rhabdoid tumor in an infant. Pediatr Neurosurg 2000;32:145–149.
  12. Crist W, Gehan EA, Ragab AH, et al: The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13:610–630.
  13. Arslanoglu A, Aygun N, Tekhtani D, Aronson L, Cohen K, Burger PC, Yousem DM: Imaging findings of CNS atypical teratoid/rhabdoid tumors. AJNR Am J Neuroradiol 2004;25:476–480.
  14. Ho DM, Hsu CY, Wong TT, Ting LT, Chiang H: Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol (Berl) 2000;99:482–488.
  15. Lath R, Unosson D, Blumbergs P, Stahl J, Brophy BP: Rhabdoid glioblastoma: a case report. J Clin Neurosci 2003;10:325–328.
  16. Perry A, Fuller CE, Judkins AR, Dehner LP, Biegel JA: INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol 2005;18:951–958.
  17. Judkins AR, Mauger J, Ht A, Rorke LB, Bie- gel JA: Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 2004;28:644–650.
  18. Tanizaki Y, Oka H, Utsuki S, Shimizu S, Suzuki S, Fujii K: Atypical teratoid/rhabdoid tumor arising from the spinal cord – case report and review of the literature. Clin Neuropathol 2006;25:81–86.
  19. Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, Krasin M, Dalton J, Hale G, Kun LE, Wallace D, Gilbertson RJ, Gajjar A: Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 2005;23:1491–1499.
  20. Packer RJ, Biegel JA, Blaney S, Finlay J, Geyer JR, Heideman R, Hilden J, Janss AJ, Kun L, Vezina G, Rorke LB, Smith M: Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol 2002;24:337–342.
  21. Korones DN, Meyers SP, Rubio A, Torres C, Constine LS: A 4-year-old girl with a ventriculoperitoneal shunt metastasis of a central nervous system atypical teratoid/rhabdoid tumor. Med Pediatr Oncol 1999;32:389–391.
  22. Guler E, Varan A, Soylemezoglu F, Kudret, Caglar F, Ba F, Demirkazik A, Buyukpamuk M: Extraneural metastasis in a child with atypical teratoid rhabdoid tumor of the central nervous system. J Neurooncol 2001;54:53–56.

Article / Publication Details

First-Page Preview
Abstract of Case Report

Received: May 21, 2007
Accepted: February 05, 2008
Published online: August 15, 2008
Issue release date: August 2008

Number of Print Pages: 8
Number of Figures: 4
Number of Tables: 2

ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)

For additional information: https://www.karger.com/PNE


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP